Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TECENTRIQ Inf Konz 1200 mg/20ml Durchstf
Drug
Tecentriq, Konzentrat zur Herstellung einer Infusionslösung
Onkologikum
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
5/23/2017
12/31/9999
Dosage strength
Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Onkologikum
01
Z – approved
Package
7680661520012
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
1200 mg atezolizumabum
histidinum
acidum aceticum glaciale
saccharum
polysorbatum 20
aqua ad iniectabile
acidum aceticum glaciale
saccharum
polysorbatum 20
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
4769.45
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Grenzacherstrasse 124
4058 Basel (BS)
Grenzacherstrasse 124
4058 Basel (BS)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.